Chronic graft-versus-host disease exacerbation after SARS-CoV-2 vaccination

Bone Marrow Transplant. 2022 Mar;57(3):502-503. doi: 10.1038/s41409-021-01543-z. Epub 2022 Jan 11.

Authors

Andrew D Trunk¹, Samuel K Shewan², Catherine J Lee¹, Charles J Parker², Daniel R Couriel³

Affiliations

¹ The University of Utah Transplant and Cellular Therapy Program, Salt Lake City, UT, USA.
² Division of Hematology and Hematologic Maligancies, University of Utah School of Medicine, Salt Lake City, UT, USA.
³ The University of Utah Transplant and Cellular Therapy Program, Salt Lake City, UT, USA. daniel.couriel@hci.utah.edu.

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Graft vs Host Disease* / etiology
Humans
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines